• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开胸二尖瓣置换术与经导管二尖瓣修复术的疗效比较;来自国家住院患者样本数据库的见解。

Outcomes of open mitral valve replacement versus Transcatheter mitral valve repair; insight from the National Inpatient Sample Database.

作者信息

Ullah Waqas, Sattar Yasar, Mukhtar Maryam, Abdullah Hafez M, Figueredo Vincent M, Haas Donald C, Fischman David L, Chadi Alraies M

机构信息

Abington Jefferson Health, Abington, USA.

Icahn school of medicine at Mount Sinai Elmhurst Hospital New York, USA.

出版信息

Int J Cardiol Heart Vasc. 2020 May 28;28:100540. doi: 10.1016/j.ijcha.2020.100540. eCollection 2020 Jun.

DOI:10.1016/j.ijcha.2020.100540
PMID:32490147
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7262433/
Abstract

BACKGROUND

Transcatheter mitral valve repair and replacement (TMVR) is a minimally invasive alternative to conventional open-heart mitral valve replacement (OMVR). The present study aims to compare the burden, demographics, cost, and complications of TMVR and OMVR.

METHODS

The United States National Inpatient Sample (US-NIS) for the year 2017 was queried to identify all cases of TMVR and OMVR. Categorical and continuous data were analyzed using Pearson chi-square and independent -test analysis, respectively. An adjusted odds ratio (aOR) based on the ordinal logistic regression (OLR) model was calculated to determine the association between outcome variables.

RESULTS

Of 19,580 patients, 18,460 (94%) underwent OMVR and 1120 (6%) TMVR. Mean ages of patients were 63 ± 14 years (OMVR) and 67 ± 13 years (TMVR). Both cohorts were predominantly Caucasian (73% OMVR vs. 74.0% TMVR). The patients who underwent TMVR were more likely to belong to a household with an income in the highest quartile (26.1% vs. 22.0% for OMVR) versus the lowest quartile (22.1% vs. 27.8%). The average number of days from admission to TMVR was less compared to OMVR (2.63 days vs. 3.02 days, p = 0.015). In-hospital length of stay (LOS) was significantly lower for TMVR compared to OMVR (11.56 vs. 14.01 days, p=<0.0001). Adjusted in-hospital mortality taking into account comorbidities showed no significant difference between the two groups (OR 1.2, 0.93-1.68, p = 0.15).

CONCLUSION

Patients undergoing TMVR were older and more financially affluent. TMVR was more costly but was associated with a shorter hospital stay and similar mortality to OMVR.

摘要

背景

经导管二尖瓣修复和置换术(TMVR)是传统开胸二尖瓣置换术(OMVR)的一种微创替代方法。本研究旨在比较TMVR和OMVR的负担、人口统计学特征、成本及并发症。

方法

查询2017年美国国家住院样本(US-NIS)以确定所有TMVR和OMVR病例。分类数据和连续数据分别采用Pearson卡方检验和独立t检验分析。基于有序逻辑回归(OLR)模型计算调整后的优势比(aOR),以确定结局变量之间的关联。

结果

在19580例患者中,18460例(94%)接受了OMVR,1120例(6%)接受了TMVR。患者的平均年龄分别为63±14岁(OMVR)和67±13岁(TMVR)。两个队列主要为白种人(OMVR占73%,TMVR占74.0%)。接受TMVR的患者更有可能来自收入处于最高四分位数的家庭(26.1%,而OMVR为22.0%),而非最低四分位数的家庭(22.1%,而OMVR为27.8%)。与OMVR相比,从入院到TMVR的平均天数更少(2.63天对3.02天,p = 0.015)。TMVR的住院时间(LOS)明显低于OMVR(11.56天对14.01天,p<0.0001)。考虑合并症后的调整后住院死亡率在两组之间无显著差异(OR 1.2, 0.93 - 1.68, p = 0.15)。

结论

接受TMVR的患者年龄更大且经济状况更富裕。TMVR成本更高,但住院时间更短,死亡率与OMVR相似。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45d9/7262433/69a6a98d2757/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45d9/7262433/939ee4edc3e7/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45d9/7262433/69a6a98d2757/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45d9/7262433/939ee4edc3e7/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45d9/7262433/69a6a98d2757/gr2.jpg

相似文献

1
Outcomes of open mitral valve replacement versus Transcatheter mitral valve repair; insight from the National Inpatient Sample Database.开胸二尖瓣置换术与经导管二尖瓣修复术的疗效比较;来自国家住院患者样本数据库的见解。
Int J Cardiol Heart Vasc. 2020 May 28;28:100540. doi: 10.1016/j.ijcha.2020.100540. eCollection 2020 Jun.
2
Transcatheter Mitral Valve Repair Versus Transcatheter Mitral Valve Replacement in Patients with Mitral insufficiency.二尖瓣反流患者经导管二尖瓣修复术与经导管二尖瓣置换术的比较
Arch Med Res. 2023 Feb;54(2):145-151. doi: 10.1016/j.arcmed.2022.12.009. Epub 2023 Jan 13.
3
Impact of age and comorbidities on the effect of transcatheter versus surgical mitral valve repair on inpatient outcomes.年龄和合并症对经导管与外科二尖瓣修复术治疗住院结局影响的比较。
Catheter Cardiovasc Interv. 2020 May 1;95(6):1195-1201. doi: 10.1002/ccd.28479. Epub 2019 Sep 2.
4
Racial and socioeconomic disparities in urgent transcatheter mitral valve repair: A National Inpatient Sample analysis.种族和社会经济差异与紧急经导管二尖瓣修复术:国家住院患者样本分析。
J Card Surg. 2021 Sep;36(9):3224-3229. doi: 10.1111/jocs.15735. Epub 2021 Jun 10.
5
Outcomes of transcatheter edge-to-edge mitral valve repair with percutaneous coronary intervention vs. surgical mitral valve repair with coronary artery bypass grafting.经导管二尖瓣缘对缘修复术联合经皮冠状动脉介入治疗与二尖瓣手术修复联合冠状动脉旁路移植术的疗效比较。
Front Cardiovasc Med. 2022 Dec 21;9:953875. doi: 10.3389/fcvm.2022.953875. eCollection 2022.
6
Redo Surgical Mitral Valve Replacement Versus Transcatheter Mitral Valve in Valve From the National Inpatient Sample.再次手术二尖瓣置换术与经导管二尖瓣置换术治疗瓣中瓣
J Am Heart Assoc. 2021 Sep 7;10(17):e020948. doi: 10.1161/JAHA.121.020948. Epub 2021 Aug 28.
7
In-hospital outcomes of transcatheter mitral valve repair in patients with and without end stage renal disease: A national propensity match study.经导管二尖瓣修复术治疗终末期肾病患者与非终末期肾病患者的院内转归:一项全国倾向匹配研究。
Catheter Cardiovasc Interv. 2021 Aug 1;98(2):343-351. doi: 10.1002/ccd.29517. Epub 2021 Feb 1.
8
Temporal Trends and Outcomes of Transcatheter Mitral Valve Repair and Surgical Mitral Valve Intervention.经导管二尖瓣修复术和外科二尖瓣干预的时间趋势及结果
Cardiovasc Revasc Med. 2020 Dec;21(12):1560-1566. doi: 10.1016/j.carrev.2020.05.021. Epub 2020 May 23.
9
Comparison of Transcatheter Mitral Valve Repair Versus Surgical Mitral Valve Repair in Patients With Advanced Kidney Disease (from the National Inpatient Sample).晚期肾病患者经导管二尖瓣修复术与外科二尖瓣修复术的比较(来自全国住院患者样本)
Am J Cardiol. 2018 Mar 15;121(6):762-767. doi: 10.1016/j.amjcard.2017.12.015. Epub 2017 Dec 25.
10
Racial Disparities in the Utilization and Outcomes of Transcatheter Mitral Valve Repair: Insights From a National Database.经导管二尖瓣修复术应用及结果中的种族差异:来自国家数据库的见解
Cardiovasc Revasc Med. 2020 Nov;21(11):1425-1430. doi: 10.1016/j.carrev.2020.04.034. Epub 2020 Apr 30.

引用本文的文献

1
Impact of diabetes mellitus type-2 on the outcomes following mitral transcatheter edge-to-edge repair (TEER): A meta-analysis.2型糖尿病对经导管二尖瓣缘对缘修复术(TEER)术后结局的影响:一项荟萃分析。
Am Heart J Plus. 2025 Jul 8;57:100574. doi: 10.1016/j.ahjo.2025.100574. eCollection 2025 Sep.
2
Predictors of acute kidney injury among octogenarians undergoing open mitral valve repair.接受二尖瓣开放修复术的八旬老人急性肾损伤的预测因素
Arch Med Sci Atheroscler Dis. 2024 Jun 22;9:e129-e132. doi: 10.5114/amsad/189732. eCollection 2024.
3
Socioeconomic Factors and their Impact on Access and Use of Coronary and Structural Interventions.

本文引用的文献

1
Temporal Trends and Outcomes of Transcatheter Mitral Valve Repair and Surgical Mitral Valve Intervention.经导管二尖瓣修复术和外科二尖瓣干预的时间趋势及结果
Cardiovasc Revasc Med. 2020 Dec;21(12):1560-1566. doi: 10.1016/j.carrev.2020.05.021. Epub 2020 May 23.
2
Emerging Technologies for Percutaneous Mitral Valve Repair.经皮二尖瓣修复的新兴技术
Front Cardiovasc Med. 2019 Nov 6;6:161. doi: 10.3389/fcvm.2019.00161. eCollection 2019.
3
Cost-Effectiveness of Transcatheter Mitral Valve Repair Versus Medical Therapy in Patients With Heart Failure and Secondary Mitral Regurgitation: Results From the COAPT Trial.
社会经济因素及其对冠状动脉和结构性干预措施的可及性与使用的影响。
Eur Cardiol. 2022 Oct 27;17:e19. doi: 10.15420/ecr.2022.23. eCollection 2022 Feb.
4
Current Unmet Needs and Clues to the Solution in the Management of Tricuspid Regurgitation.三尖瓣反流管理中的当前未满足需求及解决线索
Korean Circ J. 2022 Jun;52(6):414-428. doi: 10.4070/kcj.2022.0117.
经导管二尖瓣修复术与心力衰竭并二尖瓣反流患者药物治疗的成本效益比较:来自 COAPT 试验的结果。
Circulation. 2019 Dec 3;140(23):1881-1891. doi: 10.1161/CIRCULATIONAHA.119.043275. Epub 2019 Sep 29.
4
Early Experience With Transcatheter Mitral Valve Replacement: A Systematic Review.经导管二尖瓣置换术的早期经验:系统评价。
J Am Heart Assoc. 2019 Sep 3;8(17):e013332. doi: 10.1161/JAHA.119.013332. Epub 2019 Aug 23.
5
Complexities of transcatheter mitral valve replacement (TMVR) and why it is not transcatheter aortic valve replacement (TAVR).经导管二尖瓣置换术(TMVR)的复杂性以及它与经导管主动脉瓣置换术(TAVR)不同的原因。
Ann Cardiothorac Surg. 2018 Nov;7(6):724-730. doi: 10.21037/acs.2018.10.06.
6
Taking Transcatheter Mitral Valve Replacement to the Next Level.将经导管二尖瓣置换提升到新高度。
Circ Cardiovasc Interv. 2018 Oct;11(10):e007369. doi: 10.1161/CIRCINTERVENTIONS.118.007369.
7
Transcatheter mitral valve repair for functional mitral regurgitation using the Cardioband system: 1 year outcomes.经导管二尖瓣修复术治疗功能性二尖瓣反流:1 年结果。
Eur Heart J. 2019 Feb 1;40(5):466-472. doi: 10.1093/eurheartj/ehy424.
8
Mitral Valve Surgery: Current Minimally Invasive and Transcatheter Options.二尖瓣手术:当前的微创和经导管治疗选择
Methodist Debakey Cardiovasc J. 2016 Jan-Mar;12(1):20-6. doi: 10.14797/mdcj-12-1-20.
9
Risk and outcomes of complications during and after MitraClip implantation: Experience in 828 patients from the German TRAnscatheter mitral valve interventions (TRAMI) registry.MitraClip植入术中及术后并发症的风险与结局:来自德国经导管二尖瓣干预(TRAMI)注册研究的828例患者的经验
Catheter Cardiovasc Interv. 2015 Oct;86(4):728-35. doi: 10.1002/ccd.25838. Epub 2015 Feb 12.
10
Percutaneous transcatheter mitral valve replacement: an overview of devices in preclinical and early clinical evaluation.经皮经导管二尖瓣置换术:临床前和早期临床评估中的器械概述
Circ Cardiovasc Interv. 2014 Jun;7(3):400-9. doi: 10.1161/CIRCINTERVENTIONS.114.001607.